Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel.
Hudis
C
C
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Riccio
L
L
Seidman
A
A
Baselga
J
J
Currie
V
V
Fennelly
D
D
Gilewski
T
T
Lebwohl
D
D
Moynahan
M
M
Raptis
G
G
Surbone
A
A
Sklarin
N
N
Yao
T J
TJ
Keefe
D
D
Norton
L
L
D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013318:Stroke Volume
D004317:Doxorubicin; D017239:Paclitaxel